iPS Cells for Modelling and Treatment of Human Diseases

© 2015 MDPI; under CC BY-NC-ND license

iPSCs; liver disease; animal model; hepatic differentiation; induced pluripotent stem cells; germ cells; primordial germ cells; oocyte; sperm; gametogenesis; meiosis; assisted reproductive technology; in vitro fertilization; intracytoplasmic sperm injection; patient-specific-iPSCs-derived cardiomyocytes; regenerative medicine; modeling of inherited cardiac disorder; drug testing; toxicology studies; induced pluripotent stem cells; amyotrophic lateral sclerosis; spinal muscular atrophy; disease modeling; embryonic stem cells (ESCs); induced pluripotent stem cells (iPSCs); disease modeling; induced pluripotent stem cells; Alzheimer’s disease; disease modelling; reprogramming; induced pluripotent stem cells; Alzheimer’s disease; disease modeling; human; induced pluripotent stem cells; osteoclast; rare genetic bone disorders; age-related macular degeneration; inherited retinal disease; retinal dystrophy; macular dystrophy; retina; induced pluripotent; stem cells; cell transplantation; disease modelling; genetic diagnosis; spinal cord injury; clinical translation; neuroprotection; cell therapy; neuroregeneration; induced pluripotent stem cells; cardiomyocytes; purification; long QT syndrome; planar patch clamp; microelectrode array; PSC-derived cell therapy; iPSC; RPE; tumorigenicity test; spinal cord injury; induced pluripotent stem cells; transplantation; induced pluripotent stem cells; skeletal muscle; muscular dystrophy; myogenic progenitors; stem cell therapy; limbal stem cells; cornea; limbal stem cell deficiency; epithelial differentiation; human adult progenitor cells; ex vivo expansion; cell culture; ocular burns; cell-based therapy; human stem cells; induced pluripotent stem cells; Parkinson’s disease; Leucine-rich repeat kinase 2 (LRRK2); dopaminergic neurons; retinal disease; induced pluripotent stem cells; gene therapy; induced pluripotent stem cells; Down syndrome; trisomy 21; T21-iPSCs; reprogramming; isogenic iPSCs; congenital heart disease; hypoplastic left heart; inducible pluripotential stem cells; bioengineered myocardium; inducible; pluripotent; stem cells; autoimmunity; therapy; lupus; diabetes; multiple sclerosis